ReviewCell communication and signaling : CCS2026
Triggering receptor expressed on myeloid cell family in atherosclerosis: from mechanisms to intervention strategies.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Atherosclerosis is the leading cause of coronary artery disease (CAD). Triggering receptor expressed on myeloid cell (TREM) family members are critical regulators of lipid metabolism, inflammation and extracellular matrix metabolism during atherogenesis and thereby influence foam cell formation, vascular inflammation and plaque stability. Furthermore, soluble TREM proteins arising from the alternative splicing of TREM family mRNAs, proteolytic shedding or single nucleotide polymorphisms, hold significant diagnostic and prognostic value for CAD patients. Therefore, the importance of the TREM family in the prevention and treatment of atherosclerosis should not be underestimated. This review emphasizes the contribution of the TREM family to the pathogenesis of atherosclerosis to provide a comprehensive understanding of the roles of the TREM family in atherosclerosis. Moreover, this review summarizes the clinical significance of soluble TREM proteins in cardiovascular diseases, thereby highlighting their emerging potential as biomarkers in CAD. Finally, the molecular mechanisms regulating TREM family expression and the translational potential of strategies targeting TREM family members in atherosclerosis-associated diseases are discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.